Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Current Assets (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Current Assets readings, the most recent being $7.4 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 97.22% to $7.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.4 million, a 97.22% increase, with the full-year FY2025 number at $10.2 million, up 120.83% from a year prior.
  • Current Assets hit $7.4 million in Q1 2026 for Neuroone Medical Technologies, down from $8.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $13.4 million in Q1 2022 to a low of $3.8 million in Q1 2025.
  • Median Current Assets over the past 5 years was $7.3 million (2023), compared with a mean of $7.5 million.
  • Biggest five-year swings in Current Assets: crashed 55.36% in 2023 and later skyrocketed 148.95% in 2025.
  • Neuroone Medical Technologies' Current Assets stood at $9.0 million in 2022, then crashed by 43.2% to $5.1 million in 2023, then increased by 12.15% to $5.7 million in 2024, then soared by 41.24% to $8.1 million in 2025, then dropped by 8.22% to $7.4 million in 2026.
  • The last three reported values for Current Assets were $7.4 million (Q1 2026), $8.1 million (Q4 2025), and $10.2 million (Q3 2025) per Business Quant data.